Asston Pharmaceuticals Limited (BOM:544445)
India · Delayed Price · Currency is INR 99.75
+2.45 (2.52%)
At close: Sep 25, 2026
Asston Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Asston Pharmaceuticals had annual revenue of 254.69M INR with 1.72% growth. Asston Pharmaceuticals had revenue of 100.53M in the half year ending March 31, 2026.
Revenue
254.69M
Revenue Growth
+1.72%
P/S Ratio
4.28
Revenue / Employee
6.06M
Employees
42
Market Cap
1.09B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 254.69M | 4.30M | 1.72% |
| Mar 31, 2025 | 250.39M | 94.53M | 60.65% |
| Mar 31, 2024 | 155.86M | 90.48M | 138.39% |
| Mar 31, 2023 | 65.38M | -30.61M | -31.89% |
| Mar 31, 2022 | 95.99M | 15.64M | 19.47% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Mercury Laboratories | 737.65M |
| Amwill Health Care | 454.92M |